ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

A Custom Mouthpiece With Lip Bumper for Osteoradionecrosis Risk Reduction After Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Lip.

https://repo.qst.go.jp/records/2000490
https://repo.qst.go.jp/records/2000490
d033d86e-e49c-4800-9113-565f2c58194b
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2024-05-23
タイトル
タイトル A Custom Mouthpiece With Lip Bumper for Osteoradionecrosis Risk Reduction After Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Lip.
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Hiroaki Ikawa

× Hiroaki Ikawa

Hiroaki Ikawa

Search repository
Masashi Koto

× Masashi Koto

Masashi Koto

Search repository
Daniel K Ebner

× Daniel K Ebner

Daniel K Ebner

Search repository
Hirotoshi Takiyama

× Hirotoshi Takiyama

Hirotoshi Takiyama

Search repository
Makoto Shinoto

× Makoto Shinoto

Makoto Shinoto

Search repository
Akihiro Nomoto

× Akihiro Nomoto

Akihiro Nomoto

Search repository
Shigeru Yamada

× Shigeru Yamada

Shigeru Yamada

Search repository
Hiroshi Tsuji

× Hiroshi Tsuji

Hiroshi Tsuji

Search repository
抄録
内容記述タイプ Abstract
内容記述 The lips are a common location for minor salivary
gland tumors, including adenoid cystic carcinoma
(ACC).1 Surgery is the preferred treatment for ACC,
although patients who refuse or are ineligible for surgery
may receive radiation therapy (RT).2 However, conventional
RT is ineffective in treating ACC due to inherent radioresistance.
Carbon-ion radiation therapy (CIRT) has demonstrated
efficacy with acceptable toxicity.3 Consequently,
CIRT has been viewed as adaptable to treat ACC of the lip.
Osteoradionecrosis (ORN) is a serious adverse event in
patients with head and neck cancer who receive CIRT.
Grade ?2 maxillary ORN after CIRT was reported at
19.0% in 2014.4 Further study demonstrated that the
maxillary volume receiving >50 Gy (relative biological
effectiveness [RBE], V50) CIRT delivered in 16 fractions,
along with the inclusion of teeth within the planning target
volume (PTV), are significant independent risk factors
for ORN.4 To reduce the risk of maxillary ORN, a reduction
of V50 is required, and intraoral devices are one
modality by which the lip and jaw are positioned to
reduce the dose. However, no devices to prevent ORN
from lip cancer have been reported for CIRT.
In this technical report, we introduce and evaluate the
efficacy of a custom-made mouthpiece with a lip bumper
for the reduction of maxilla V50 in patients with ACC of
the lip(s) treated with CIRT.
書誌情報 Advances in radiation oncology

巻 8, 号 1, p. 101114, 発行日 2024-01
出版者
出版者 Elsevier
ISSN
収録物識別子タイプ ISSN
収録物識別子 2452-1094
PubMed番号
識別子タイプ PMID
関連識別子 36471821
DOI
識別子タイプ DOI
関連識別子 10.1016/j.adro.2022.101114
戻る
0
views
See details
Views

Versions

Ver.1 2025-08-15 02:21:26.830222
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3